Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2100-2103
Published online before print August 9, 2007, doi: 10.1161/ATVBAHA.107.147918
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/10/2100    most recent
ATVBAHA.107.147918v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lusis, A. J.
Right arrow Articles by Wang, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lusis, A. J.
Right arrow Articles by Wang, S. S.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2100.)
© 2007 American Heart Association, Inc.


Brief Reviews

The Problem of Passenger Genes in Transgenic Mice

Aldons J. Lusis; Janet Yu; Susanna S. Wang

From the Department of Microbiology, Immunology, and Molecular Genetics, Department of Medicine/Division of Cardiology, and Department of Human Genetics, University of California, Los Angeles.

Correspondence to Aldons J. Lusis, PhD, UCLA School of Medicine, BH-307 CHS, Los Angeles, CA 90095-1679. E-mail jlusis{at}mednet.ucla.edu

Gene targeted or transgenic mice are frequently created on one genetic background and the mutation then transferred to a second genetic background by a series of backcrosses, with selection for the mutation at each generation. This is the same experimental design as that used in the production of classical congenic strains in which a genomic region from a "donor" strain is transferred to the background of a "recipient" strain by backcrossing and selection for ten or more generations. While the strategy largely results in the replacement of the donor background with the recipient background, the region flanking the selected gene remains of donor origin. Thus, the genes in this flanking region are "passengers" that travel with the selected gene, and when comparing transgenic (or knockout) mice with non-transgenic littermates, allelic differences in the passenger genes can conceivably influence the traits of interest. It now appears that this passenger gene effect may be an important confounder in studies of cardiovascular and metabolic traits that are influenced by dozens of common variations present among inbred mouse strains. Here, we discuss the problem and some approaches to avoid it.


Key Words: gene targeting • genetic background




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
Z. Su, X. Wang, S.-W. Tsaih, A. Zhang, A. Cox, S. Sheehan, and B. Paigen
Genetic basis of HDL variation in 129/SvImJ and C57BL/6J mice: importance of testing candidate genes in targeted mutant mice
J. Lipid Res., January 1, 2009; 50(1): 116 - 125.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. L. Svenson, N. Ahituv, R. S. Durgin, H. Savage, P. A. Magnani, O. Foreman, B. Paigen, and L. L. Peters
A new mouse mutant for the LDL receptor identified using ENU mutagenesis
J. Lipid Res., November 1, 2008; 49(11): 2452 - 2462.
[Abstract] [Full Text] [PDF]